Physician profile
Brian M Clark
NPI 1164686572
$2,660.67
in general payments reported to CMS, 2019-2025
17 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $132 · 2021: $388 · 2022: $136 · 2023: $783 · 2024: $344 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $357.69 | 2019-2025 | Acuvue |
| Coopervision INC. | $307.51 | 2019-2022 | |
| Alcon Vision LLC | $278.68 | 2021-2024 | Total30 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $273.81 | 2019-2021 | |
| Abbvie INC. | $224.71 | 2023-2024 | Vuity, Alphagan P, Lumigan |
| Bausch & Lomb Americas INC. | $211.25 | 2022-2025 | Vyzulta, Miebo, Infuse |
| Oyster Point Pharma, INC. | $177.60 | 2023-2024 | Tyrvaya |
| Shire North American Group INC | $139.82 | 2019 | |
| Kala Pharmaceuticals, INC. | $136.64 | 2021 | |
| Astellas Pharma US INC | $119.70 | 2023 | |
| Novartis Pharmaceuticals Corporation | $117.08 | 2019-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $103.72 | 2019 | |
| Harrow Eye, LLC | $81.36 | 2024-2025 | Vevye |
| Allergan, INC. | $65.94 | 2019-2022 | |
| Biotissue Holdings INC. | $30.68 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $22.52 | 2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.